Across TCGA pan-cancer cohorts, RNU6-465P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-465P data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNU6-465P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-465P expression acts as an unfavorable survival marker.
SKCM are the cancer types where RNU6-465P RNA most reproducibly stratifies survival.